Multidisciplinary Treatment of Advanced Soft Tissue Sarcomas

Multidisciplinary Treatment of Advanced Soft Tissue Sarcomas

Episodes

Specialty:

All

Year:

All

EP. 1: Incidence and Subtypes of Advanced Soft Tissue Sarcoma

October 21st 2015

EP. 2: Accurately Diagnosing Soft Tissue Sarcoma

October 21st 2015

EP. 3: Multidisciplinary Assessment of Soft Tissue Sarcomas

October 21st 2015

EP. 4: Implementation of Multidisciplinary Sarcoma Care

October 21st 2015

EP. 5: Key Members of the Multidisciplinary Team

October 21st 2015

EP. 6: Integrating Community Oncologists Into the Multidisciplinary Team

October 21st 2015

EP. 7: Importance of Surgery and Radiation in Advanced STS

October 21st 2015

EP. 8: Chemotherapy Regimens for Advanced Soft Tissue Sarcoma

October 21st 2015

EP. 9: Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma

October 21st 2015

EP. 10: Subtyping in Soft Tissue Sarcoma: The PALLETTE Study

October 21st 2015

EP. 11: Use of Trabectedin in Soft Tissue Sarcoma

October 21st 2015

EP. 12: Patient Selection in Soft Tissue Sarcoma

October 21st 2015

EP. 13: Early Data With Olaratumab in Soft Tissue Sarcoma

October 21st 2015

EP. 14: Phase III Data on Eribulin in Advanced STS

October 21st 2015

EP. 15: Future Directions in Soft Tissue Sarcoma

October 21st 2015

Trending on OncLive

FDA Approves Nogapendekin Alfa Inbakicept Plus BCG for High-Grade, Papillary-Only BCG-Unresponsive NMIBC

SurVaxM Cancer Vaccine Shows Clinically Meaningful OS Signal in Newly Diagnosed Glioblastoma

VS-7375 Elicits Responses in KRAS G12D–Mutated Pancreatic Cancer

FDA Receives NDA Resubmission for Rivoceranib Plus Camrelizumab in Frontline Unresectable or Metastatic HCC

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer